Graphique du cours de l'action BLRX
BLRX Gagner
BioLineRx Ltd.
$3.1
-7.46%
$-0.25
À la fermeture : May 07, 16:00:00 GMT-4
$3.1
0%
$0
Post-Marché: May 07, 20:00:00 GMT-4
Retour
BioLineRx Ltd. (BLRX) Gagner
Statistiques clés
Clôture préc.
$3.35
Prix d'ouverture
$3.29
Plage de la journée
$3.1 - $3.33
Plage de 52 semaines
$2.15 - $7.77
Volume
13.5K
Volume moyen
18.3K
Rendement en dividend
--
BPA (TTM)
0.00
Capitalisation boursière
$13.4M
Qu’est-ce que BioLineRx Ltd. ?
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. The company is headquartered in Modiin, Central(Hamerkaz) and currently employs 24 full-time employees. The company went IPO on 2007-01-30. The firm is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The firm is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
Fonctionnalités
© 2026 Edgen fonctionné par